secwatch.observer — SEC 8-K summary
======================================

Issuer:     SeaStar Medical Holding Corp (ICU)
CIK:        0001831868
Form:       8-K
Filed at:   2026-03-25T23:59:59+00:00
Accession:  0001437749-26-009780
Event type: earnings
Sentiment:  positive
Materiality: 0.65
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

SeaStar Medical Q4 2025 revenue $420K; net loss narrows to $2.9M; cash grows to $12M
--------------------------------------------------------------------------------

- Net revenue Q4 2025 $420K (vs $67K Q4 2024); full year $1.2M (vs $135K).
- Net loss Q4 2025 $2.9M ($0.80/share) vs $4.4M ($8.98/share) Q4 2024; cash $12.0M (up from $1.8M).
- QUELIMMUNE expanded to 16 children's hospitals; SAVE Registry enrollment completed (50 patients).
- NEUTRALIZE-AKI trial >50% enrolled (181/339); modular PMA submission for adult AKI initiated.
- Guides 2026 net product revenue ~$2M; plans to add 15 more hospital sites.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1831868/000143774926009780/0001437749-26-009780-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1831868/000143774926009780/icu20260313_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-26-009780

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer